| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention concerns medicine, namely immunology, and can be used for prevention of recurrence and treatment of herpes virus infections. Method is implemented as follows. In remission period, synthetic dipeptide gamma-D-glutamyl-L-tryptophan is introduced intranasally in a dose 50-100 mcg daily within 7-10 days. In exacerbation period, synthetic dipeptide gamma-D-glutamyl-L-tryptophan is introduced intranasally in a dose 100 mcg daily within 10 days within integrated antiviral therapy involving preparations valaciclovir 500 mg orally 1 tablet twice a day - 5-10 days, penciclovir for external application on affected areas 3-4 times a day within 5-7 days. ^ EFFECT: invention enables reductions of acute period and prolonged recurrence of herpes virus infection due to normalisation of amount of T-helpers, T-suppressors, NK cells and their relations, intensified formation of endogenous interferon. ^ 3 tbl, 1 ex
|
